As Hormone Use Increases, Some Doctors Warn Slight Cancer Risk Is Being Overlooked
Doctors warn of slight cancer risk with hormone therapy for menopause
145 trends tracked about this subject — the full history, oldest to newest below.
Doctors warn of slight cancer risk with hormone therapy for menopause
Multiple studies link 2-3 cups of coffee daily to a 43% lower risk of liver cancer, with benefits seen for both caffeinated and decaf coffee.
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Boston researchers uncover new clues explaining why colorectal cancer behaves so aggressively in younger patients.
A physician who spent fifteen years studying breast cancer has received a personal diagnosis of the exact disease.
Pfizer raises its full-year outlook and beats Q3 expectations as it pivots toward cancer and weight-loss medications in a post-pandemic recovery.
Stanford researchers have identified a protein translation pathway involving the METTL13 enzyme that drives cancer growth and drug resistance.
Recent coverage examines lung cancer causes in nonsmokers as rates rise and awareness campaigns promote early screening.
GSK anticipates its oncology clinical pipeline will nearly double in 2027 following an aggressive period of dealmaking and strategic acquisitions.
Incyte presents new early clinical data at ESMO for its KRAS G12D-targeted pancreatic and colorectal cancer medicine.
Pittsburgh cancer doctors and precision oncology editors explain why less treatment can sometimes mean better outcomes.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Roche's new lung-cancer drug divarasib shows superior survival rates compared to rivals in late-stage trials, targeting the emerging oncology market.
AstraZeneca is showcasing a new portfolio of targeted cancer therapies, featuring a stomach cancer drug that significantly extended patient survival times.
A landmark trial reveals the first successful cancer vaccine, reducing the risk of melanoma recurrence or death by 42%.
Researchers unveil an artificial intelligence face-scanning technology that uses a single photograph to predict cancer treatment survival.
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
US cancer patients are traveling to China to access innovative oncology therapies and lifesaving drugs not yet available within the United States.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Discussions on lung cancer screening barriers have surged across major outlets following high-profile diagnoses and recent medical symposia.
Indian-American oncologist and cancer researcher Dr. Rachna Shroff dies at the age of 47, according to recent media reports.
Recent studies examine connections between sugary drink consumption, stomach cancer risk, and the broader myths surrounding sugar and cancer.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
24 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Cancer vaccines emerge as a major focus for the N.I.H. amid growing clinical developments.
Recent studies reveal that restricting inherited cancer gene testing by age leaves thousands of carriers undetected.
Recent scientific studies and medical reports examine a preinvasive regulatory T cell axis and immune fog for lung cancer interception.
Recent health reports indicate a rise in prostate cancer survival rates, attributed to medical breakthroughs and an increase in men seeking diagnoses.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Researchers have unveiled an epigenetic blueprint that explains how the 'undruggable' MYC gene drives aggressive cancer amplification.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Genmab releases new phase 2 data for its antibody-drug conjugate, prompting claims of superiority over rival treatments.
The oncology community is facing critical questions as divergent trial results emerge regarding the efficacy and scale of cancer vaccines.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New research indicates that approximately 1 in 8 cancer cases worldwide are tied to infections, highlighting the critical role of preventative vaccines.
Grail faces lingering reimbursement hurdles despite approaching a landmark FDA approval for its Galleri cancer blood test.
Recent studies show a simple urine test analyzing cell-free RNA can detect bladder cancer and track treatment.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
11 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent scientific studies reveal distinct gut microbiome patterns linked to five cancer groups and early-onset cancers.
Recent coverage highlights new artificial intelligence tools enabling women to assess their breast cancer risk.
Recent coverage examines how scientists cracked the RAS mutation in pancreatic cancer and explores Arizona connections to the breakthrough treatment.
A multi-cancer early detection blood test draws investor enthusiasm and trial data coverage across major financial and health outlets.
Recent coverage details a major milestone in pancreatic cancer treatment with the approval of daraxonrasib and new laboratory breakthroughs.
New developments in personalized mRNA cancer vaccines show promise for melanoma and breast cancer, though hurdles in public perception remain.
A new IARC study reveals that five specific infections are responsible for over 2 million new cancer cases annually, accounting for nearly one in eight worldwide.
Advances in personalized mRNA vaccines are showing promise in treating melanoma, though experts warn that misinformation may hinder their adoption.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
23 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent findings show five-treatment radiotherapy matches surgery and conventional radiation for prostate cancer.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent coverage examines the intersection of artificial intelligence and cancer research, raising questions about progress and expectations.
14 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.